Related Experiment Video
Updated: Nov 4, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
The Staufen1-dependent cell cycle regulon or how a misregulated RNA-binding protein leads to cancer
Florence Bonnet-Magnaval1, Luc DesGroseillers1
1Département de biochimie et médecine moléculaire, Faculté de médecine, Université de Montréal, 2900 Édouard Montpetit, Montréal, QC, H3T 1J4, Canada.
Abstract:
In recent years, an increasing number of reports have linked the RNA-binding protein Staufen1 (STAU1) to the control of cell decision making. In non-transformed cells, STAU1 balances the expression of messenger RNA (mRNA) regulons that regulate differentiation and well-ordered cell division. Misregulation of STAU1 expression and/or functions changes the fragile balance in the expression of pro- and anti-proliferative and apoptotic genes and favours a novel equilibrium that supports cell proliferation and cancer development. The misregulation of STAU1 functions causes multiple coordinated modest effects in the post-transcriptional regulation of many RNA targets that code for cell cycle regulators, leading to dramatic consequences at the cellular level. The new tumorigenic equilibrium in STAU1-mediated gene regulation observed in cancer cells can be further altered by a slight increase in STAU1 expression that favours expression of pro-apoptotic genes and cell death. The STAU1-dependent cell cycle regulon is a good model to study how abnormal expression of an RNA-binding protein promotes cell growth and provides an advantageous selection of malignant cells in the first step of cancer development.
Insights
The RNA-binding protein Staufen1 (STAU1) regulates cell division and differentiation. Its misregulation in cancer promotes cell proliferation and tumor development, offering potential therapeutic targets.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Biology
Background:
- Staufen1 (STAU1) is an RNA-binding protein implicated in controlling cellular decisions.
- In normal cells, STAU1 maintains a balance in gene expression crucial for differentiation and cell division.
- Dysregulation of STAU1 disrupts this balance, promoting cancer development.
Purpose of the Study:
- To investigate the role of Staufen1 (STAU1) in cell proliferation and cancer development.
- To understand how STAU1 misregulation contributes to the tumorigenic equilibrium.
- To explore STAU1 as a potential target for cancer therapy.
Main Methods:
- Analysis of STAU1's role in post-transcriptional regulation of RNA targets.
- Examination of STAU1-mediated gene regulation in cancer cells.
- Study of the STAU1-dependent cell cycle regulon.
Main Results:
- STAU1 misregulation leads to altered expression of cell cycle regulators, favoring proliferation.
- Cancer cells exhibit a tumorigenic equilibrium influenced by STAU1.
- Increased STAU1 expression can promote apoptosis, suggesting a dual role.
Conclusions:
- STAU1 plays a critical role in maintaining cellular homeostasis and its dysregulation is a key factor in cancer initiation.
- The STAU1-dependent cell cycle regulon serves as a model for understanding RNA-binding protein-driven oncogenesis.
- Targeting STAU1 may offer a strategy to combat cancer by restoring apoptotic pathways.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules
Positive Regulator Molecules
Positive Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

